Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Air, allergic, area, Australia, autoimmune, bad, build, Care, complement, congenital, Department, differentiated, downgrade, draft, drove, duration, environmental, expand, experience, failure, Germany, GmbH, goal, HHD, high, IIa, immunoregulatory, inability, irreversible, Justice, kidney, licensure, located, modified, Moody, Munich, nonstrategic, OBIZUR, occurrence, offer, perception, Pfizer, Pollution, porcine, prepaid, profile, promptly, realign, realigned, realignment, recast, recruit, repaid, shift, SuppreMol, tender, Thousand, topline, unfunded, unmet, Ventura, violation
Removed:
accelerated, achievement, achieving, advance, advanced, arising, artificially, assumption, award, BioPharma, brought, buying, candidate, Carlo, Chatham, collaborative, compound, conspired, council, determine, devalued, direct, equipment, establishment, exclusive, expiration, favorably, flat, FLOSEAL, geographic, globulin, grant, hard, heavily, holder, holding, Human, implied, Indap, initial, Inspiration, insurance, integrate, introduced, Ipsen, LLC, lowered, Lund, membership, memorandum, microsurgery, Monte, obtaining, Onconova, open, outlining, output, percent, pertaining, Pharma, Pharmaceuticalsprincipally, pilot, point, Poor, preliminary, pretrial, primary, proposed, PSU, pursue, ranging, receive, reduction, reflecting, repair, repurchased, restrict, rigosertib, satisfying, September, service, soft, Specialty, specific, spent, stayed, strategy, submission, Subsequent, substantial, Sweden, SYNDEO, Systemsprincipally, TISSEEL, tranche, transformation, updated, vaccine, vesting, voting, weighted, weighting
Filing tables
Filing exhibits
Related press release
BAX similar filings
Filing view
External links
EXHIBIT 15
May 6, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We are aware that our report dated May 6, 2015 on our review of interim financial information of Baxter International Inc. (the “company”) for the three-month periods ended March 31, 2015 and 2014 and included in the company’s quarterly report on Form 10-Q for the quarter ended March 31, 2015 is incorporated by reference in its Registration Statements on Form S-8 (Nos. 333-43563, 333-47019, 333-88257, 333-48906, 333-62820, 333-102140, 333-104420, 333-104421, 333-105032, 333-143063, 333-174400 and 333-174401) and on Form S-3 (Nos. 333-123811 and 333-183099).
Very truly yours,
/s/ PricewaterhouseCoopers LLP
Chicago, Illinois